ALT-22913-39215
2 vaccinations
7 coded responses
23 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 289 / NC
- Registered
- 2021-04-13
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- N/A
Timeline
-
2021-04-13
Registered in v-safe
-
2021-04-13
Dose 1 — Pfizer-BioNTech
-
2021-04-13
Survey response — day 0, dose 1MedDRA: Dizziness, Feeling abnormal, Immediate post-injection reaction — Feeling: Fair · Site: Redness, Swelling · Fatigue or tirednessFree text: I felt a little lightheaded, almost stoned, immediately after the injection. I havent used any substances that would lead to that type of feeling.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-04-16
Survey response — days 1–6 daily, dose 1MedDRA: Injection site mass — Feeling: Good · Site: Pain, Redness, Swelling · Headache, Joint pains, Fatigue or tirednessFree text: Theres a knot-like lump at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Injection site mass — Feeling: Good · Site: Redness, SwellingFree text: I still have dark bruising and a lump at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessFree text: Intense bruising at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · Joint pains, Fatigue or tirednessAdult check-in
-
2021-04-20
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Redness · Chills, Fatigue or tirednessAdult check-in
- 2021-04-27
-
2021-05-03
Dose 2 — Pfizer-BioNTech
-
2021-05-03
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-04
Survey response — days 1–6 daily, dose 2MedDRA: Asthenia — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Incredibly low energyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-10
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-09
- 2021-06-14
-
2021-08-02
Survey response — 3 months, dose 2MedDRA: Osteonecrosis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Avascular necrosis of the scaphoidMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-02
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-13
- 2021-08-17
-
2021-11-01
Survey response — 6 months, dose 2MedDRA: Hypogeusia, Hyposmia, Major depression, Nasal congestion, Osteonecrosis — Feeling: Fair · Be unable to work or attend schoolFree text: Avascular necrosis of the scaphoid, reduced smell and taste, shrunken nasal passageways, major depression, etc.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Pfizer-BioNTech | |
| 2 | 2021-05-03 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): I felt a little lightheaded, almost stoned, immediately after the injection. I havent used any substances that would lead to that type of feeling.
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Theres a knot-like lump at the injection site
Systemic reaction (other): I still have dark bruising and a lump at the injection site
Systemic reaction (other): Intense bruising at the injection site
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Incredibly low energy
Release 9 — 3 months, dose 2
Symptoms: Avascular necrosis of the scaphoid
Release 10 — 6 months, dose 2
Symptoms: Avascular necrosis of the scaphoid, reduced smell and taste, shrunken nasal passageways, major depression, etc.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypogeusia | · | · | ✓ |
| SD | Hyposmia | · | · | ✓ |
| SD | Major depression | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Osteonecrosis | ✓ | · | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release